About Molecular Staging
Molecular Staging is a company based in New Haven (United States) founded in 1998. It operates as a B2B and Direct Sales. Molecular Staging has raised $49.55 million across 14 funding rounds from investors including Orbimed, Investor and OSTI.GOV. Molecular Staging offers products and services including Protein Microarrays, Whole-Genome Amplification, and Multiplexed Diagnostics. Molecular Staging operates in a competitive market with competitors including Abcam, Stem Cell Technologies, DnaNudge, OriGene and Sangon Biotech, among others.
- Headquarter New Haven, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Molecular Staging Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$49.55 M (USD)
in 14 rounds
-
Latest Funding Round
$640.39 K (USD), Grant
Apr 26, 2011
-
Investors
Orbimed
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Molecular Staging
Molecular Staging offers a comprehensive portfolio of products and services, including Protein Microarrays, Whole-Genome Amplification, and Multiplexed Diagnostics.
High-coverage arrays for studying multiple proteins simultaneously in research.
Amplification method making DNA samples renewable for repeated testing.
Ultra-sensitive tests for early disease detection and cost reduction.
Funding Insights of Molecular Staging
Molecular Staging has successfully raised a total of $49.55M across 14 strategic funding rounds. The most recent funding activity was a Grant round of $640.39 thousand completed in April 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Molecular Staging
Molecular Staging has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Orbimed, Investor and OSTI.GOV.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed by the Wallenberg family into Nordic sectors.
|
Locked | Locked | Locked | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Molecular Staging
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Molecular Staging
Investment portfolio details for Molecular Staging
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Molecular Staging
Detailed financials for Molecular Staging
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Molecular Staging Comparisons
Peer comparison for Molecular Staging
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Molecular Staging
Molecular Staging operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, DnaNudge, OriGene and Sangon Biotech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Developer of cell culture media and ancillary reagents for life science research
|
|
| Locked | Locked | Locked |
Lab-on-chip wearable systems for genetic diagnosis are provided.
|
|
| Locked | Locked | Locked |
Proteins, antibodies, and molecular tools are manufactured for research applications.
|
|
| Locked | Locked | Locked |
Research services, reagents, and kits for biotech applications are provided.
|
|
| Locked | Locked | Locked |
Molecular diagnostic device and kits
|
Detailed competitors of Molecular Staging
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Molecular Staging
Complete news archive for Molecular Staging
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Molecular Staging
Molecular Staging was founded in 1998.
Molecular Staging is headquartered in New Haven, United States. It is registered at New Haven, Connecticut, United States.
Molecular Staging is a funded company, having raised a total of $49.55M across 14 funding rounds to date.
Molecular Staging Inc. focuses on innovative technologies for the detection and measurement of proteins and nucleic acids, addressing demands in the life science industry. It offers products like protein microarrays and whole-genome amplification to enable faster genomics and proteomics analysis. Based in San Jose, United States, the company serves researchers and healthcare markets by developing gene-based tests and immunoassays for diseases such as cancer and infectious disorders, emphasizing sensitivity and multiplexing advantages.
Molecular Staging's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.
Molecular Staging offers Protein Microarrays, Whole-Genome Amplification, and Multiplexed Diagnostics.